In this report, the Asia-Pacific Perphenazine Market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.
Perphenazine is a psychiatric drug that is basically used to treat a mental disorder such as schizophrenia, schizoaffective disorder, and the manic phase of bipolar disorder. This drug help to reduce the nervousness, aggressive behavior, and also helps to reduce the desire for the self-hurting. Moreover, it also helps to decrease the hallucinations by balancing the certain natural chemicals present in brain i.e. Dopamine. perphenazine is marketed as Trilafon, available in tablet form and is considered as medium-potency antipsychotic drug. It has action at all levels of the central nervous system especially the hypothalamus. Moreover, this medicine works by changing the actions of chemicals in the brain. However, perphenazine is not advisable for a patient with liver disease, brain damages, bone marrow depression, and blood cell disorder such as low platelets or low blood cell counts. Furthermore, this medicine used when patients when other antipsychotics drugs are ineffective.
Rising cases of a neurological disorder such as schizophrenia in the Asia Pacific region is expected to propel the market growth of perphenazine. Moreover, increasing expenditure on pharmaceutical industry by government and companies are also launching new drug in order to cater to the rising need for treating the neurological disorder. For instance, in June 2017, Teva has launched its generic of Trilafon (perphenazine) tablets. The drug is indicated to treat schizophrenia and to control severe nausea and vomiting in adults.
Furthermore, growing awareness regarding the neurological disorder in the region coupled with the increasing initiatives by the government to improve the medical facilities is expected to foster the growth of the Asia pacific perphenazine market. Additionally, growing FDA approval for novel drugs in order to meet the growing need coupled with the expanding pharmaceutical industry in the region is also expected to foster the market growth of perphenazine. According to the India Brand Equity Foundation, the Indian pharmaceutical sector was valued at US$ 33 billion in 2017. The pharmaceutical industry is projected to expand at a CAGR of 22.4 percent over 2015–20 to reach US$ 55 billion. India’s pharmaceutical exports stood at US$ 17.27 billion in FY18 and have reached US$ 19.14 billion in FY19.
Key developments:
- In April 2018, Otsuka Pharmaceutical Co., Ltd. announced the launch in Japan of REXULTI® Tablets (chemical name is brexpiprazole) in 1 mg and 2 mg tablets for the treatment of patients with schizophrenia. REXULTI is already available to patients in the U.S., Canada, and Australia.
- In September 2019, Sumitomo Dainippon Pharma Co., Ltd. announced the launch of a transdermal patch formulation of atypical antipsychotic LONASEN® Tape 20 mg, 30 mg, and 40 mg (generic name: blonanserin, hereinafter, “this Drug”) in Japan
Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Perphenazine for these regions, from 2018 to 2025 (forecast), including
╼ China
╼ Japan
╼ South Korea
╼ Taiwan
╼ India
╼ Southeast Asia
╼ Australia
Asia-Pacific Perphenazine market competition by top manufacturers/players, with Perphenazine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
╼ Sandoz
╼ Actavis
╼ Qualitest
╼ Mylan
╼ Tianjing Lisheng Pharm
╼ Sinapharm
╼ Beijing Zhongxin Pharm
╼ Changzhou Siyao Pharm
╼ Shanghai Fuxing Pharm
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
╼ Tablet
╼ Injection
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Perphenazine for each application, including
╼ Antipsychotics
╼ Antiemetic
[**NOTE: If you have any special requirements, please let us know and we will offer you the report as you want.]
Table of Contents
Asia-Pacific Perphenazine Market Report 2019
1 Perphenazine Overview
1.1 Product Overview and Scope of Perphenazine
1.2 Classification of Perphenazine by Product Category
1.2.1 Asia-Pacific Perphenazine Market Size (Sales) Comparison by Types (2014-2024)
1.2.2 Asia-Pacific Perphenazine Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Tablet
1.2.4 Injection
1.3 Asia-Pacific Perphenazine Market by Application/End Users
1.3.1 Asia-Pacific Perphenazine Sales (Volume) and Market Share Comparison by Applications (2014-2024)
1.3.2 Antipsychotics
1.3.3 Antiemetic
1.4 Asia-Pacific Perphenazine Market by Region
1.4.1 Asia-Pacific Perphenazine Market Size (Value) Comparison by Region (2014-2024)
1.4.2 China Status and Prospect (2014-2024)
1.4.3 Japan Status and Prospect (2014-2024)
1.4.4 South Korea Status and Prospect (2014-2024)
1.4.5 Taiwan Status and Prospect (2014-2024)
1.4.6 India Status and Prospect (2014-2024)
1.4.7 Southeast Asia Status and Prospect (2014-2024)
1.4.8 Australia Status and Prospect (2014-2024)
1.5 Asia-Pacific Market Size (Value and Volume) of Perphenazine (2014-2024)
1.5.1 Asia-Pacific Perphenazine Sales and Growth Rate (2014-2024)
1.5.2 Asia-Pacific Perphenazine Revenue and Growth Rate (2014-2024)
2 Asia-Pacific Perphenazine Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Perphenazine Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Perphenazine Sales Volume and Market Share of Key Players/Suppliers (2014-2019)
2.1.2 Asia-Pacific Perphenazine Revenue and Share by Players/Suppliers (2014-2019)
2.2 Asia-Pacific Perphenazine (Volume and Value) by Type
2.2.1 Asia-Pacific Perphenazine Sales and Market Share by Type (2014-2019)
2.2.2 Asia-Pacific Perphenazine Revenue and Market Share by Type (2014-2019)
2.3 Asia-Pacific Perphenazine (Volume) by Application
2.4 Asia-Pacific Perphenazine (Volume and Value) by Region
2.4.1 Asia-Pacific Perphenazine Sales and Market Share by Region (2014-2019)
2.4.2 Asia-Pacific Perphenazine Revenue and Market Share by Region (2014-2019)
3 China Perphenazine (Volume, Value and Sales Price)
3.1 China Perphenazine Sales and Value (2014-2019)
3.1.1 China Perphenazine Sales Volume and Growth Rate (2014-2019)
3.1.2 China Perphenazine Revenue and Growth Rate (2014-2019)
3.1.3 China Perphenazine Sales Price Trend (2014-2019)
3.2 China Perphenazine Sales Volume and Market Share by Type
3.3 China Perphenazine Sales Volume and Market Share by Application
4 Japan Perphenazine (Volume, Value and Sales Price)
4.1 Japan Perphenazine Sales and Value (2014-2019)
4.1.1 Japan Perphenazine Sales Volume and Growth Rate (2014-2019)
4.1.2 Japan Perphenazine Revenue and Growth Rate (2014-2019)
4.1.3 Japan Perphenazine Sales Price Trend (2014-2019)
4.2 Japan Perphenazine Sales Volume and Market Share by Type
4.3 Japan Perphenazine Sales Volume and Market Share by Application
5 South Korea Perphenazine (Volume, Value and Sales Price)
5.1 South Korea Perphenazine Sales and Value (2014-2019)
5.1.1 South Korea Perphenazine Sales Volume and Growth Rate (2014-2019)
5.1.2 South Korea Perphenazine Revenue and Growth Rate (2014-2019)
5.1.3 South Korea Perphenazine Sales Price Trend (2014-2019)
5.2 South Korea Perphenazine Sales Volume and Market Share by Type
5.3 South Korea Perphenazine Sales Volume and Market Share by Application
6 Taiwan Perphenazine (Volume, Value and Sales Price)
6.1 Taiwan Perphenazine Sales and Value (2014-2019)
6.1.1 Taiwan Perphenazine Sales Volume and Growth Rate (2014-2019)
6.1.2 Taiwan Perphenazine Revenue and Growth Rate (2014-2019)
6.1.3 Taiwan Perphenazine Sales Price Trend (2014-2019)
6.2 Taiwan Perphenazine Sales Volume and Market Share by Type
6.3 Taiwan Perphenazine Sales Volume and Market Share by Application
7 India Perphenazine (Volume, Value and Sales Price)
7.1 India Perphenazine Sales and Value (2014-2019)
7.1.1 India Perphenazine Sales Volume and Growth Rate (2014-2019)
7.1.2 India Perphenazine Revenue and Growth Rate (2014-2019)
7.1.3 India Perphenazine Sales Price Trend (2014-2019)
7.2 India Perphenazine Sales Volume and Market Share by Type
7.3 India Perphenazine Sales Volume and Market Share by Application
8 Southeast Asia Perphenazine (Volume, Value and Sales Price)
8.1 Southeast Asia Perphenazine Sales and Value (2014-2019)
8.1.1 Southeast Asia Perphenazine Sales Volume and Growth Rate (2014-2019)
8.1.2 Southeast Asia Perphenazine Revenue and Growth Rate (2014-2019)
8.1.3 Southeast Asia Perphenazine Sales Price Trend (2014-2019)
8.2 Southeast Asia Perphenazine Sales Volume and Market Share by Type
8.3 Southeast Asia Perphenazine Sales Volume and Market Share by Application
9 Australia Perphenazine (Volume, Value and Sales Price)
9.1 Australia Perphenazine Sales and Value (2014-2019)
9.1.1 Australia Perphenazine Sales Volume and Growth Rate (2014-2019)
9.1.2 Australia Perphenazine Revenue and Growth Rate (2014-2019)
9.1.3 Australia Perphenazine Sales Price Trend (2014-2019)
9.2 Australia Perphenazine Sales Volume and Market Share by Type
9.3 Australia Perphenazine Sales Volume and Market Share by Application
10 Asia-Pacific Perphenazine Players/Suppliers Profiles and Sales Data
10.1 Sandoz
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Perphenazine Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Sandoz Perphenazine Sales, Revenue, Price and Gross Margin (2014-2019)
10.1.4 Main Business/Business Overview
10.2 Actavis
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Perphenazine Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Actavis Perphenazine Sales, Revenue, Price and Gross Margin (2014-2019)
10.2.4 Main Business/Business Overview
10.3 Qualitest
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Perphenazine Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Qualitest Perphenazine Sales, Revenue, Price and Gross Margin (2014-2019)
10.3.4 Main Business/Business Overview
10.4 Mylan
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Perphenazine Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Mylan Perphenazine Sales, Revenue, Price and Gross Margin (2014-2019)
10.4.4 Main Business/Business Overview
10.5 Tianjing Lisheng Pharm
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Perphenazine Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Tianjing Lisheng Pharm Perphenazine Sales, Revenue, Price and Gross Margin (2014-2019)
10.5.4 Main Business/Business Overview
10.6 Sinapharm
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Perphenazine Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Sinapharm Perphenazine Sales, Revenue, Price and Gross Margin (2014-2019)
10.6.4 Main Business/Business Overview
10.7 Beijing Zhongxin Pharm
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Perphenazine Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Beijing Zhongxin Pharm Perphenazine Sales, Revenue, Price and Gross Margin (2014-2019)
10.7.4 Main Business/Business Overview
10.8 Changzhou Siyao Pharm
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Perphenazine Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Changzhou Siyao Pharm Perphenazine Sales, Revenue, Price and Gross Margin (2014-2019)
10.8.4 Main Business/Business Overview
10.9 Shanghai Fuxing Pharm
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Perphenazine Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Shanghai Fuxing Pharm Perphenazine Sales, Revenue, Price and Gross Margin (2014-2019)
10.9.4 Main Business/Business Overview
11 Perphenazine Manufacturing Cost Analysis
11.1 Perphenazine Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Perphenazine
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Perphenazine Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Perphenazine Major Manufacturers in 2016
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change
15 Asia-Pacific Perphenazine Market Forecast (2019-2024)
15.1 Asia-Pacific Perphenazine Sales Volume, Revenue and Price Forecast (2019-2024)
15.1.1 Asia-Pacific Perphenazine Sales Volume and Growth Rate Forecast (2019-2024)
15.1.2 Asia-Pacific Perphenazine Revenue and Growth Rate Forecast (2019-2024)
15.1.3 Asia-Pacific Perphenazine Price and Trend Forecast (2019-2024)
15.2 Asia-Pacific Perphenazine Sales Volume, Revenue and Growth Rate Forecast by Region (2019-2024)
15.2.1 Asia-Pacific Perphenazine Sales Volume and Growth Rate Forecast by Region (2019-2024)
15.2.2 Asia-Pacific Perphenazine Revenue and Growth Rate Forecast by Region (2019-2024)
15.2.3 China Perphenazine Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.4 Japan Perphenazine Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.5 South Korea Perphenazine Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.6 Taiwan Perphenazine Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.7 India Perphenazine Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.8 Southeast Asia Perphenazine Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.9 Australia Perphenazine Sales, Revenue and Growth Rate Forecast (2019-2024)
15.3 Asia-Pacific Perphenazine Sales, Revenue and Price Forecast by Type (2019-2024)
15.3.1 Asia-Pacific Perphenazine Sales Forecast by Type (2019-2024)
15.3.2 Asia-Pacific Perphenazine Revenue Forecast by Type (2019-2024)
15.3.3 Asia-Pacific Perphenazine Price Forecast by Type (2019-2024)
15.4 Asia-Pacific Perphenazine Sales Forecast by Application (2019-2024)
16 Research Findings and Conclusion
17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer
Request Discount 
Inquire Before Buy
